相关实验视频

Updated: Jan 18, 2026

Serum and Plasma Copy Number Detection Using Real-time PCR

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

在人体血中稳定阿比拉,使用乙酶抑制剂Bis(4-尼托) 酸盐

Maaike A C Bruin^1,2, Luc Lucas¹, Jos H Beijnen^1,2,3

¹Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Therapeutic drug monitoring

|May 29, 2025

概括

乙酶抑制剂 bis(4-尼托) 酸盐 (BNPP) 在室温下稳定阿比拉在人体血中至少5天. 这一发现支持在前列腺癌治疗中对阿比拉的治疗药物监测的实施.

科学领域:

药理学药理学是指药理学的学科.
分析化学分析化学
临床化学临床化学

背景情况:

阿比拉酸对于前列腺癌治疗至关重要,但其活性代谢物阿比拉在血中迅速降解.
短暂的血稳定性 (在室温下4小时) 阻碍了阿比拉的治疗药物监测 (TDM).
雌激酶抑制剂被探索以改善TDM的阿比拉稳定性.

研究的目的:

为了评估 bis(4-nitrophenyl) 酸盐 (BNPP) 在人类血中稳定abiraterone的疗效.
评估BNPP对abiraterone分析的准确性,精度,选择性和特异性的影响.

主要方法:

在K2EDTA血中使用1毫米和10毫米的BNPP测试了阿比拉稳定.
样品通过验证的液体染色学质谱法 (LC-MS/MS) 方法进行分析.
部分验证证实了BNPP与分析方法的兼容性.

主要成果:

10毫米的BNPP有效地防止了在室温下至少5天的阿比拉降解.
亿元的BNPP并没有提供显著的稳定.
部分验证证实,BNPP并没有对试验性能产生负面影响.

结论:

双4-尼托) 酸盐 (BNPP) 是人类血中阿比拉的有效稳定剂.
BNPP不会干扰阿比拉的LC-MS/MS分析.
补充BNPP可以促进阿比拉TDM的临床实施,以改善前列腺癌的治疗.

关键词:

美国国家公安局 BNPP BNPP 时间 TDM TDM 一个是abiraterone.这是一种雌激酶抑制剂.稳定的稳定性稳定的稳定性

更多相关视频

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...